Skip to main content

Table 3 Studies which demonstrated an increased incidence of malignancy with systemic immunosuppressive therapy in IED

From: Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?

Risk of malignancy

References

8 malignancies were observed in 69 patients with ocular pemphigoid treated with cyclophosphamide and prednisone therapy (2 BCC, 2 SCC, 2 leukemias and 1 breast carcinoma)

[31]

537 patients treated with systemic corticosteroids and/or immunosuppressive therapy found no significant difference between groups treated with immunosuppressive (n = 330) and the control (n = 207), p > 0.90

[32]

46 patients treated with systemic immunosuppressive agents for uveitis were examined for malignancy incidence during a 5-year follow-up and compared to patients who only received corticosteroid therapy; 8 malignancies occurred in the experimental group in comparison to 2 in the control (p < 0.05)

[33]